Latest Articles

Publication Date
The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study | Scientific Reports - Nature.com

The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study | Scientific Reports Nature.com

Published: Feb. 12, 2024, 8 a.m.
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca - Wiley Online Library

Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca Wiley Online Library

Published: Feb. 11, 2024, 8 a.m.
FDA Approves GSK's Jemperli For Expanded Use In Endometrial Cancer - Contract Pharma

FDA Approves GSK's Jemperli For Expanded Use In Endometrial Cancer Contract Pharma

Published: Feb. 8, 2024, 8 a.m.
HER2 ADCs in Endometrial Cancer: Shaping the Treatment Landscape - OncLive

HER2 ADCs in Endometrial Cancer: Shaping the Treatment Landscape OncLive

Published: Feb. 1, 2024, 8 a.m.
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer - OncLive

Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer OncLive

Published: Jan. 26, 2024, 8 a.m.
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer - Nature.com

Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer Nature.com

Published: Jan. 17, 2024, 8 a.m.
A substantial step toward earlier endometrial cancer detection - Mayo Clinic

A substantial step toward earlier endometrial cancer detection Mayo Clinic

Published: Jan. 9, 2024, 8 a.m.
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis - Nature.com

SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis Nature.com

Published: Jan. 8, 2024, 8 a.m.
TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway - Nature.com

TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway Nature.com

Published: Jan. 3, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!